
Everything you need to know about the MOC process.

Everything you need to know about the MOC process.

An overview of Behavioral Neurology and Neuropsychiatry, a medical specialty committed to better understanding links between neuroscience and behavior and to the care of individuals with neurologically based behavioral disturbances.

The term “CTE” was introduced recently to describe progressive neuropathological changes and diffuse neuropsychiatric symptoms associated with a history of TBI. Here, a clinical overview of TBI and CTE.

Psychiatric comorbidity in epilepsy represents not only a matter of intellectual interest but also an important variable that affects prognosis in terms of morbidity and mortality.

For some patients with Parkinson disease, the neuropsychiatric complications are a greater source of morbidity than the motor dysfunction. This article focuses on the management of psychosis in Parkinson disease.

As with most tests in medicine, the results of computerized neurocognitive tests are not diagnostic, but they are useful adjuncts to the diagnostic process.

The universe of psychiatric ethics has dramatically expanded. Let us boldly go together where psychiatric ethics has never gone before!

Case-based dialogues illustrate some virtues required in psychiatric practice.

As psychiatrists, we have a potentially unique-and powerful-influence in the discussion of public figures. But what professional and ethical obligations should we follow in this role?

Federal law now strongly supports a patient’s right to view his or her psychiatric record on request. Here: a look at the ethical and legal issues.

Psychiatry in China? Up until about a decade ago, that could have been considered an oxymoron. Yet, just as China has modernized and embraced a Chinese form of capitalism, so psychiatry is becoming modernized in a Chinese form of psychiatry.

How will economic development influence management of population aging so that the dignity and rights of older persons are respected and protected, particularly those who are vulnerable because of mental illness, social isolation, or physical debility? Insights here.

It may be difficult for our American and European colleagues to imagine the constraints under which Russian psychiatrists practice. In Russia, treatment of the psychiatric population is at the mercy of government and society.

How prevalent is dependence on amphetamines, cocaine, opioids, and other illicit drugs across the world? What is the associated disease burden? Insights here.

The authors focus on the epidemiology of postpartum psychosis, its clinical presentation, etiology, treatment, and strategies to prevent its recurrence.

Alzheimer disease psychosis appears to be a distinct clinical entity. This article focuses on management strategies.

In the first of a two-part Special Report, the evaluation and management of psychosis is explored across a range of disorders and clinical contexts.

The first generation of cognitive-behavioral therapy for psychosis, when added to standard care, has demonstrated efficacy in treating patients with delusions and hallucinations. Details in this article.

Information from studies on adolescents with psychosis and a review of the evidence about the risk of suicide and suicidal behavior in this patient population.

Various populations of patients can benefit from telepsychiatry. The goal is not to replace local mental health resources but to enhance existing capabilities. This article articulates successful interventions as well as topics to consider when developing a telepsychiatry service.

Articles on stigma, telepsychiatry, and designer drugs . . . matters germane, timely, and needed-that is what is here for you, our readers. Enjoy and learn.

At a moment when mental health is so much at the forefront of the minds of Americans and our media, it seems time, again, to try to understand the damaging views so commonly held about people with mental illness.

Psychiatrists are urged to familiarize themselves with these new drugs and the typical presentations of patients who use them since implications of misdiagnosis can be far-reaching.

There are a number of well-established niches in psychiatry, from forensics to addictions to LGBT. This author relates how she established her niche as a sports psychiatrist.

There have been considerable advances in the research on and clinical use of neurostimulation for psychiatric disorders, especially mood disorders and MDD. Three of the most recognized are reviewed here. An experimental new treatment-- trigeminal nerve stimulation-- is also briefly discussed.

Clearly, old age is associated with unavoidable decline but in some instances can be mitigated by mental and physical exercise and social activity. How is the preservation of function despite illness and decline accomplished? Insights here. . .

Psychiatric Times asked this psychiatrist to compile and edit a series worthy of its readers’ attention. We hope you find that this special section has achieved the literary and professional standards we set.

Half of all mental health disorders occur by age 14. Early interventions may mitigate progression to more serious and persistent mental health concerns.

Older Latinos with depression report higher levels of impairment and are more persistently ill than non-Hispanic white older adults, yet they have lower rates of guideline-concordant treatment. Cognitive and problem-solving psychosocial modalities are emerging as key treatment considerations for older Latinos.

A risk to benefit ratio of treatment must be established to determine the optimal treatment for perimenopausal depression. Untreated depression during the perimenopause exacerbates heart disease, diabetes, and osteoporosis. Details about management options here.